- Home
- MRKR vs GP Comparison
MRKR vs GP Comparison
Compare MRKR & GP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRKR
- GP
- Stock Information
- Founded
- MRKR N/A
- GP 2010
- Country
- MRKR United States
- GP Canada
- Employees
- MRKR N/A
- GP N/A
- Industry
- MRKR Biotechnology: Pharmaceutical Preparations
- GP Construction/Ag Equipment/Trucks
- Sector
- MRKR Health Care
- GP Consumer Discretionary
- Exchange
- MRKR Nasdaq
- GP Nasdaq
- Market Cap
- MRKR 11.6M
- GP 9.4M
- IPO Year
- MRKR N/A
- GP 2020
- Fundamental
- Price
- MRKR $1.02
- GP $2.99
- Analyst Decision
- MRKR Strong Buy
- GP
- Analyst Count
- MRKR 3
- GP 0
- Target Price
- MRKR $13.17
- GP N/A
- AVG Volume (30 Days)
- MRKR 317.3K
- GP 77.8K
- Earning Date
- MRKR 11-13-2025
- GP 11-13-2025
- Dividend Yield
- MRKR N/A
- GP N/A
- EPS Growth
- MRKR N/A
- GP N/A
- EPS
- MRKR N/A
- GP N/A
- Revenue
- MRKR $5,388,071.00
- GP $18,399,688.00
- Revenue This Year
- MRKR N/A
- GP $81.12
- Revenue Next Year
- MRKR $9.35
- GP $91.69
- P/E Ratio
- MRKR N/A
- GP N/A
- Revenue Growth
- MRKR 44.55
- GP N/A
- 52 Week Low
- MRKR $0.81
- GP $2.28
- 52 Week High
- MRKR $5.95
- GP $18.50
- Technical
- Relative Strength Index (RSI)
- MRKR 51.53
- GP 57.31
- Support Level
- MRKR $0.97
- GP $2.87
- Resistance Level
- MRKR $1.08
- GP $3.38
- Average True Range (ATR)
- MRKR 0.07
- GP 0.23
- MACD
- MRKR 0.01
- GP -0.12
- Stochastic Oscillator
- MRKR 60.50
- GP 22.35
About MRKR Marker Therapeutics Inc.
Marker Therapeutics Inc is a clinical-stage immuno-oncology company specializing in the development and commercialization of novel T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company develops product candidates from its MultiTAA T cell technology, which is based on the selective expansion of non-engineered, tumor-specific T cells that recognize tumor-associated antigens, or TAAs, which are tumor targets, and then kill tumor cells expressing those targets.
About GP GreenPower Motor Company Inc.
GreenPower Motor Co Inc is the manufacturer and distributor of all-electric charter, school, and city buses. The company offers electric-powered transit buses deploying electric drive and battery technologies with a lightweight chassis and low-floor body. Its product line includes all-electric transit buses, all-electric school buses, and shuttle buses. The company's buses depend on clean sheet design and utilize a custom battery management system and a proprietary flex power system for the drive motors. Geographically, the company generates a majority of its revenue from the United States of America and the rest from Canada.